- Prevail Therapeutics (NASDAQ:PRVL): Q2 GAAP EPS of -$0.58 beats by $0.66.
- More news on: Prevail Therapeutics Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
Market Wire News is a media platform, the information on this page was provided by SeekingAlpha via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
Prevail Therapeutics Inc. Company Name:
PRVL Stock Symbol:
Market:
Prevail Therapeutics Inc. Website:
NEW YORK, NY / ACCESSWIRE / January 8, 2021 / Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City, is investigating: Altimar Acquisition Corp. (NYSE: ATAC ) relat...
Shares of Eli Lilly (NYSE: LLY) jumped by 6% on Tuesday. The healthy gain came after the drugmaker raised its full-year 2020 revenue and earnings guidance, and provided a positive outlook for 2021. Lilly also announced plans to acquire Prevail Therapeutics (NASDAQ: PRVL) . ...
Eli Lilly (NYSE: LLY) will soon add a new asset to its portfolio. The veteran pharmaceutical company announced on Tuesday that it has signed a definitive agreement to acquire gene therapy specialist Prevail Therapeutics (NASDAQ: PRVL) . The price is $22.50 per share in c...